{
    "SPADE_UN_21772": {
        "Sequence Information": {
            "Peptide Name": "R-DIM-P-LF11-322",
            "Sequence": "PFWRIRIRRPRRIRIRWFP",
            "Sequence Length": 19,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.",
                    "Pubmed ID": "26239537",
                    "Reference": "Biochim Biophys Acta. 2015;1848:2918-2931",
                    "Author": "Riedl S, Leber R, Rinner B, Schaider H, Lohner K, Zweytick D",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26239537"
                },
                {
                    "Title": "Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.",
                    "Pubmed ID": "32151609",
                    "Reference": "Biochim Biophys Acta. 2020;1862:183264",
                    "Author": "Grissenberger S, Riedl S, Rinner B, Leber R, Zweytick D",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32151609"
                }
            ],
            "Mass": 2678.24,
            "PI": 12.0,
            "Net Charge": 8,
            "Hydrophobicity": -1.0,
            "Frequent Amino Acids": "RIP",
            "Absent Amino Acids": "ACDEGHKLMNOQSTUVY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 13,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_21772",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_00507",
                    "Similarity": 1.0,
                    "Sequence": "PFWRIRIRR"
                },
                {
                    "SPADE_ID": "SPADE_UN_15560",
                    "Similarity": 1.0,
                    "Sequence": "RFRRPIRRRPIRPPFWR"
                },
                {
                    "SPADE_ID": "SPADE_UN_15566",
                    "Similarity": 1.0,
                    "Sequence": "RFRWPIRRRPIRPPFWR"
                }
            ],
            "Hemolytic Activity": "Human dermal fibroblasts:LC50=63.6±1.3 µM,Human epidermal melanocytes:LC50=22.0±0.9 µM",
            "Target Organism": "Human melanoma A375(LC50=4.2±0.2µM),Human Melanoma SBcl-2(LC50=2.5±0.1µM),Human metastatic melanoma WM164(LC50=4.7±0.2µM),Human rhabdomyosarcoma TE671(10-20% Killing=20µM),Human glioblastoma U251-MG(80-90% Killing=20µM)"
        }
    }
}